Results 81 to 90 of about 4,501 (207)
Trials, 2020 Background Diabetes mellitus is associated with risk of sudden sensorineural hearing loss (SSNHL). Systemic and intratympanic corticosteroids are the two primary treatments for SSNHL in patients with diabetes mellitus.
Weiqiang Yang +7 more
doaj +1 more source
Intratympanic gentamicin for Ménière's disease or syndrome
Cochrane Database of Systematic Reviews, 2010 Ménière's disease is characterised by three major symptoms: vertigo, deafness and tinnitus, which may be accompanied by aural fullness, all of which are discontinuous and variable in intensity. While discontinuous, these symptoms are synchronous. Intratympanic application of gentamicin, an ototoxic aminoglycoside, is a relatively new ablative treatment
Pullens, Bas, van Benthem, Peter Paul
openaire +2 more sources
Cochlear Implantation in Autoimmune Inner‐Ear Disease: Outcome and Patient‐Reported Benefit
The Laryngoscope, Volume 136, Issue 9, Page 3980-3989, September 2026.This study demonstrates that patients with secondary autoimmune inner‐ear disease (AIED) achieve significant improvements in speech perception and quality of life following cochlear implantation. Although AIED patients may show slightly lower performance in noisy environments compared to controls, their subjective hearing benefit converges with matched
Merete Hartmann +4 more
wiley +1 more source
Intratympanic corticosteroid perfusion in the therapy of Meniere’s disease [PDF]
, 2014 Introduction Over the last two decades the intratympanic perfusion of corticosteroids has been used as a minimally invasive surgical therapy of Meniere's disease.
Ivanković, Zoran +9 more
core +3 more sources
Intratympanic prednisolone therapy for sudden sensorineural hearing loss: A new protocol
, 2010 Conclusion: Intratympanic administration of prednisolone at a dose of 62.5 mg/ml performed every day for 3 consecutive days is more efficacious than the therapeutic approaches described so far in the literature.
BALSAMO, GIORGIO +7 more
core +1 more source
مجله دانشکده پزشکی اصفهان, 2009 Background: Intratympanic steroid injection is an effective method in treatment of sudden sensorineural hearing loss in cases resisted to systemic therapy. The purpose of this study was to determine the efficacy of intratympanic injection.
Seyed Mostafa Hashemi +4 more
doaj
Modified intratympanic treatment for idiopathic sudden sensorineural hearing loss
, 2009 PubMedID: 19862543Steroids are the only proven drugs in the treatment for idiopathic sudden sensorineural hearing loss. In the recent studies, it has been suggested that, steroids delivered through the intratympanic route obtained higher perilymph levels,
Kara E. +7 more
core +1 more source
, 2011 The purpose of this study was to investigate the effectiveness of intratympanic dexamethasone injection as a therapeutic agent against cisplatin-induced ototoxicity. Animals were randomly divided into three groups.
Oncel, Semih +9 more
core +1 more source
The protective effect of intratympanic dexamethasone on cisplatin‐induced ototoxicity in guinea pigs
, 2007 OBJECTIVE: The purpose of this study was to investigate the effectiveness of intratympanic dexamethasone injection as a protection agent against cisplatin-induced ...
Bulent Serbetcioglu +5 more
core +1 more source
Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis
, 2010 Hypothesis: Intratympanic steroid treatment prevents hearing loss and cochlear damage in a rat model of pneumococcal meningitis. Background: Sensorineural hearing loss is a long-term complication of meningitis affecting up to a third of survivors ...
Caye-Thomasen, P. +11 more
core +1 more source